Cargando…

Advances in NKT cell Immunotherapy for Glioblastoma

Type I or invariant natural killer T cells belong to a unique lineage of innate T cells, which express markers of both T lymphocytes and NK cells, namely T cell receptor (TCR) and NK1.1 (CD161C), respectively. Thus, apart from direct killing of target cells like NK cells, and they also produce a myr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyaram, Kalyani, Yadav, Viveka Nand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108592/
https://www.ncbi.nlm.nih.gov/pubmed/30147849
http://dx.doi.org/10.4172/1948-5956.1000533
_version_ 1783350168117051392
author Pyaram, Kalyani
Yadav, Viveka Nand
author_facet Pyaram, Kalyani
Yadav, Viveka Nand
author_sort Pyaram, Kalyani
collection PubMed
description Type I or invariant natural killer T cells belong to a unique lineage of innate T cells, which express markers of both T lymphocytes and NK cells, namely T cell receptor (TCR) and NK1.1 (CD161C), respectively. Thus, apart from direct killing of target cells like NK cells, and they also produce a myriad of cytokines which modulate the adaptive immune responses. Unlike traditional T cells which carry a conventional αβ TCR, NKT cells express semi-invariant TCR – Vα14-Jα18, coupled with Vβ8, Vβ7 and Vβ2 in mice. In humans, the invariant TCR is composed of Vα24-Jα18, coupled with Vβ11.
format Online
Article
Text
id pubmed-6108592
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-61085922018-08-24 Advances in NKT cell Immunotherapy for Glioblastoma Pyaram, Kalyani Yadav, Viveka Nand J Cancer Sci Ther Article Type I or invariant natural killer T cells belong to a unique lineage of innate T cells, which express markers of both T lymphocytes and NK cells, namely T cell receptor (TCR) and NK1.1 (CD161C), respectively. Thus, apart from direct killing of target cells like NK cells, and they also produce a myriad of cytokines which modulate the adaptive immune responses. Unlike traditional T cells which carry a conventional αβ TCR, NKT cells express semi-invariant TCR – Vα14-Jα18, coupled with Vβ8, Vβ7 and Vβ2 in mice. In humans, the invariant TCR is composed of Vα24-Jα18, coupled with Vβ11. 2018-06-18 2018 /pmc/articles/PMC6108592/ /pubmed/30147849 http://dx.doi.org/10.4172/1948-5956.1000533 Text en This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Article
Pyaram, Kalyani
Yadav, Viveka Nand
Advances in NKT cell Immunotherapy for Glioblastoma
title Advances in NKT cell Immunotherapy for Glioblastoma
title_full Advances in NKT cell Immunotherapy for Glioblastoma
title_fullStr Advances in NKT cell Immunotherapy for Glioblastoma
title_full_unstemmed Advances in NKT cell Immunotherapy for Glioblastoma
title_short Advances in NKT cell Immunotherapy for Glioblastoma
title_sort advances in nkt cell immunotherapy for glioblastoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108592/
https://www.ncbi.nlm.nih.gov/pubmed/30147849
http://dx.doi.org/10.4172/1948-5956.1000533
work_keys_str_mv AT pyaramkalyani advancesinnktcellimmunotherapyforglioblastoma
AT yadavvivekanand advancesinnktcellimmunotherapyforglioblastoma